BAHATTIN ERGIN: Open Payments
NPI 1386312023 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 19 payments from 7 companies in 2025. Trend: 2023 $475 · 2024 $715 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 9 | $273 |
| Indivior Inc. | 5 | $170 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Almatica Pharma LLC | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Neos Therapeutics, LP | 1 | $15 |
Products named: Azstarys, SUBLOCADE, Qelbree, Auvelity, LOREEV XR, HETLIOZ, Adzenys XR-ODT.
Industry payments across FL — which companies pay providers there.
